sIgA

Elevated levels in saliva are associated with an immune response to stimulation by infections and inflammatory reactions. High levels of SIgA production may indicate an infection of the digestive system, in which case a Comprehensive Stool Analysis with parasites would be recommended.

Causes of elevated fecal sIgA:

- Any defective epithelial barrier

- A defective epithelial barrier allows bacterial and microbial penetration, which is the strongest stimulator of sIgA production.

- Celiac disease

- Colon cancer

- Infections

- IBS (especially the diarrhea subtype)

Therapeutic considerations for elevated fecal sIgA:

Assess for and treat root causes of immune upregulation /inflammation:

- Infection (bacterial, parasitic, and/or viral pathogen, potential pathogen)

- Compromised intestinal barrier function (i.e., intestinal permeability)

- Heightened response to noninfectious stimuli (i.e., food sensitivity/allergy, etc.)

Consider Food Antibody testing – If positive, consider elimination diet

SIgA key function is to bind to invading micro organisms and toxins and entrap them in the mucus layer or within the epithelial cells [=cells that cover the inside and outside of the surfaces of your body], so inhibiting microbial motility, agglutinating the organisms and neutralising their exotoxins and then assist in their harmless elimination from the body in the faecal flow.

SIgA also 'tags' food as acceptable, so low SIgA leads to increased sensitivity to foods. Several studies link stress and emotionality with levels of SIgA.

Production is adversely affected by stress, which is mediated by cortisol levels. This could result in inadequate production of SIgA in response to a mucosal infection. Reduced SIgA levels may be associated with sub optimal adrenal output, in which case an adrenal stress index test would be recommended.

Causes of Low sIgA:

- Certain drugs can induce transient IgA deficiency which resolve after the causative drugs are removed. These include anti-inflammatories, sulfasalazine, hydantoin, cyclosporine, gold, fenclofenac, sodium valproate, and captopril.

- Certain viral infections, such as congenital rubella infection or Epstein-Barr virus (EBV) infection, may result in persistent IgA deficiency.

- Patients with poor nutrition may have difficulty mounting an appropriate immune response.

- Lower sIgA levels are frequently found in those with ulcerative colitis or in those whose first degree relatives have the disease. Research has shown a dysfunction in transepithelial IgA secretion, and thus a decrease in sIgA.

- A high antigenic load can result in depressed sIgA, even in healthy, asymptomatic individuals.

- Lower levels are found in those with excessive cortisol production, so decreasing stress may lead to higher sIgA levels.

- Lower levels may also be found in those with chronic infections or immune hypersensitivity. The decrease in resistance can lead to dysbiosis and an increased risk of infection and allergy.

Considerations for low fecal sIgA:

Because of the lack of clinical evidence, there is no clear cut-off value for low fecal sIgA. People with systemic IgA deficiency can have low levels of fecal secretory IgA. There is a demonstrated link between IgA deficiency and several GI diseases, including:

- celiac disease,

- giardiasis,

- nodular lymphoid hyperplasia,

- ulcerative colitis,

- Crohn’s disease,

- pernicious anemia,

- and gastric and colonic adenocarcinoma.

Low sIgA may reflect a loss of GI immune response resiliency. Fecal sIgA may be low in severe/prolonged IBD patients due to a switch from intestinal IgA to IgG production as well as a deficiency in producing IgA dimers and polymers.

Secretory IgA demonstrates an array of activities integral to the maintenance of intestinal homeostasis. It influences the composition of intestinal microbiota, down-regulates pro-inflammatory responses normally associated with the uptake of highly pathogenic bacteria and potentially allergenic antigens, and promotes the retro-transport of antigens across the intestinal epithelium to gut-associated lymphoid tissue (GALT). Therefore, a low sIgA is clinically significant.

The test result should be considered together with any other medical condition, other biomarkers, and microbiome profiles when interpreting the data.

Ways to Increase sIgA:

Treating the overall gut, with exclusion or rotation diets, glutamine, fish oils for inflammation, and the entire 4-R program includes:

Treatment Using Four “R” Program for Intestinal Health:

- Remove offending foods, medications, gluten (if sensitive) and reduce high fat foods, refined carbohydrates, sugars, and fermented foods (if yeast is present). Consider antimicrobial, antifungal, and/ or antiparasitic therapies in the case of opportunistic/ pathogenic bacterial, yeast, and/or parasite overgrowth (see otherrecommendations below).

- Replace what is needed for normal digestion and absorption such as betaine HCl, pancreatic enzymes, herbs that aid in digestion such as deglycyrrhizinated licorice and marshmallow root, dietary fiber, and water.

- Reinoculate with favorable microbes (probiotics such as Lactobacillus sp., Bifidobacter sp., and Saccharomyces boulardii). To enhance the growth of the favorable bacteria, supplement with prebiotics such as insulin, xylooligosaccharides, and fiber.

- Repair mucosal lining by giving support to healthy intestinal mucosal cells, goblet cells, and to the immune system. Consider L-glutamine, essential fatty acids, zinc, pantothenic acid and vitamin C.

Other Recommendations for Increasing sIgA:

- Exercise and relaxation techniques (such as footbaths, aromatherapy and massage) have been shown to increase sIgA levels.

- Decrease cortisol levels. Cortisol can direct the production of immune cells immuncytes, which produce sIgA.

- Probiotics (bifidobacter and Lactobacillus bacteria) have been shown to increase sIgA (as well as beneficial short chain fatty acids). They may also activate macrophages.

- Saccharomyces boulardii is used for the prevention and treatment of diarrhea of different etiologies and has been shown to enhance IgA immune response.

SIGA (Secretory IgA) is the primary antibody that is protecting us from pathogens and toxins from penetrating mucosal surfaces. Its role is crucial in protecting the integrity of the intestinal epithelium. The antibody blocks the access to the epithelial receptors and traps pathogens and toxins in the mucus which are then excreated by peristaltic movements.